Intero Biosystems Sells Gut Organoids for Drug Testing

Intero Biosystems is selling lab-grown intestinal models to drug developers as the Food and Drug Administration encourages non-animal approaches, while the models’ ability to predict human drug responses remains unestablished. The company markets its GastroScreen organoids for safety and efficacy testing and disease modeling. The models are made from induced pluripotent stem cells and designed to include epithelial, mesenchymal, muscle, neuronal and endothelial cells. Intero’s product page lists live or frozen vials containing more than 100 viable organoids.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.